Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

20.39USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$20.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
63,278
52-wk High
$22.41
52-wk Low
$17.68

Summary

Name Age Since Current Position

G. Walter Loewenbaum

72 2002 Independent Chairman of the Board

Nachum Shamir

63 2014 President, Chief Executive Officer, Director

Harriss Currie

55 2013 Chief Financial Officer, Senior Vice President - Finance, Treasurer

Richard Rew

49 2015 Senior Vice President, General Counsel, Secretary

Todd Bennett

47 2016 Senior Vice President - Global Sales and Customer Operations

Nancy Fairchild

63 2015 Senior Vice President - Human resources

Tadd Lazarus

60 2016 Senior Vice President

Randall Myers

55 2015 Senior Vice President - Global Manufacturing and Quality

Robert Cresci

73 1996 Independent Director

Stephen Eck

65 2016 Independent Director

Thomas Erickson

66 2004 Independent Director

Jim Kever

64 1996 Independent Director

Kevin McNamara

61 2003 Independent Director

Edward Ogunro

64 2009 Independent Director

Matthew Scalo

2017 Senior Director, Investor Relations

Biographies

Name Description

G. Walter Loewenbaum

Mr. G. Walter Loewenbaum, II, is an Independent Chairman of the Board of Luminex Corp. He served as Vice Chairman of the Board of Directors from April 1998 until January 2000. Mr. Loewenbaum also has served as chairman of the board of directors of 3D Systems since September 1999, and was previously chairman of the board of directors of Envoy. He holds a B.A. from the University of North Carolina. Mr. Loewenbaum became involved with Luminex as an original investor in Luminex prior to our initial public offering. As an investment banker and private equity investor, Mr. Loewenbaum has worked with multiple companies in a variety of different industries at different phases of organizational development, ranging from startup to publicly traded. He brings depth of knowledge in serving as chairman for public and private companies, building stockholder value and capital market considerations. Mr. Loewenbaum also provides continuity to the Board of Directors, given his service on the Board since Luminex's earliest years of operation.

Nachum Shamir

Mr. Nachum Shamir is President, Chief Executive Officer, Director of Luminex Corporation. From 2006 to 2014, Mr. Shamir was the President, Chief Executive Officer and Director of Given Imaging Ltd., a developer of the PillCam capsule and manufacturer and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH, a manufacturer and distributor of a single use and computer-assisted colonoscopy system. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Harriss Currie

Mr. Harriss T. Currie is Chief Financial Officer, Senior Vice President - Finance, Treasurer of the Company. Since joining Luminex in November of 1998, Mr. Currie previously served in the capacities of Controller and Treasurer. Prior to joining us, he was employed as the chief financial officer, secretary and treasurer of SpectraCell Laboratories, a specialized clinical testing laboratory company, from 1993 to 1998 where he also served as vice president of finance for two subsidiary companies. Mr. Currie earned his B.B.A. from Southwestern University and his M.B.A. in Finance and Marketing from The University of Texas at Austin. Prior to returning to graduate school for his M.B.A., Mr. Currie was a certified public accountant with Deloitte & Touche LLP.

Richard Rew

Mr. Richard W. Rew II is Senior Vice President, General Counsel and Corporate Secretary of the Company. Prior to joining the Company, Mr. Rew served as Senior Vice President, General Counsel and Secretary at ArthroCare Corporation (ArthroCare), a medical device company, from December 2008 until it was acquired by Smith & Nephew in 2014. Mr. Rew joined ArthroCare in 2006 as its Vice President, Legal Affairs. Mr. Rew previously served as General Counsel of Activant Solutions Inc. from 2000 to 2006 and as General Counsel of EZCORP, Inc. from 1996 to 2000. Mr. Rew earned a B.A. in the Plan II Honors Program from the University of Texas at Austin and a J.D. from the University of Oklahoma College of Law. Mr. Rew is a Member of the State Bar of Texas.

Todd Bennett

Mr. Todd C. Bennett is Senior Vice President - Global Sales and Customer Operations of the Company. Mr. Bennett joined Luminex in October 2012 as General Manager, Americas. Mr. Bennett was promoted to Vice President, Global Sales and Customer Operations in July 2015 and to Senior Vice President, Global Sales and Customer Operations in November 2016. From January 2007 through March 2012, Mr. Bennett was the Vice President of Sales and then promoted to Vice President of Commercial Operations at Immucor, Inc., a provider of transfusion and transplantation products, where he was responsible for Commercial Operations (Sales, Global Marketing, Customer Service functions). Prior to Immucor, Mr. Bennett held various commercial leadership roles at Roche Diagnostics and Abbott Laboratories dating to 1994. Mr. Bennett holds a B.S. in Business Administration with an emphasis in finance from the Max M. Fisher College of Business at The Ohio State University in Columbus, Ohio.

Nancy Fairchild

Ms. Nancy M. Fairchild is Senior Vice President - Human Resources of the Company. She was promoted to Vice President, Human Resources in August 2012 and to Senior Vice President, Human Resources in January 2015. Prior to Luminex, Ms. Fairchild served as Chief Administrative Officer and Vice President of Human Resources and Organizational Development for the Electric Reliability Council of Texas which provides the energy grid services for Texas, from 2006 to 2010. In this role she managed Strategic Planning, Project Management, Facilities and Human Resources. Earlier in her career, she served as Vice President, Human Resources for Esoterix, Inc., an international healthcare company specializing in laboratory services, from 2001 to 2006, the Senior Vice President of Human Resources for Southern Union Company, a large natural gas conglomerate, from 1989 to 2001, and President of EnergyWorX, a training subsidiary, from 1996 to 2000. Ms. Fairchild is currently a member of the Board of Directors and Chair of the Audit Committee for Workforce Solutions, a local workforce development board in Texas, representing the biotech sector. She graduated with highest honors from Texas State University with a B.S. degree in Math Education and an M.S. degree in Counseling.

Tadd Lazarus

Dr. Tadd S. Lazarus is a Senior Vice President, Chief Medical Officer of the Company. Dr. Lazarus has responsibility for Medical Affairs, Regulatory Affairs, Reimbursement, as well as Health and Public Policy. Prior to joining the Company, Dr. Lazarus served as Chief Medical Officer and Head of Medical & Scientific Affairs, Reimbursement and Public Policy at QIAGEN N.V. from 2013 to 2016. Dr. Lazarus previously served as Chief Medical Officer and Vice President, Clinical Affairs at Gen-Probe Incorporated (acquired by Hologic, Inc.) from 2010 to 2012. Before joining the industry in 1998, Dr. Lazarus served as Medical Director of HIV Ambulatory Care Programs at the former St. Vincent’s Hospital and Medical Center in New York City. Dr. Lazarus holds a B.S. in Biology and Physiology from Marlboro College, an M.D. from Ross University School of Medicine, and has completed postgraduate training in Internal Medicine at Englewood Hospital and Medical Center in Englewood, New Jersey.

Randall Myers

Mr. Randall Myers is Senior Vice President, Global Manufacturing and Quality of the company. Prior to joining the Company, Mr. Myers accepted an early retirement from Applied Materials, Inc. (Applied Materials), a supplier of equipment services and software to enable the manufacture of semiconductor, flat panel display, glass, WEB and solar products, in 2012 and had been consulting in supply chain and manufacturing operations since that time. Prior to his retirement from Applied Materials, Mr. Myers held various positions at Applied Materials in manufacturing and operations from 1995-2012. In his final position with Applied Materials, Mr. Myers was Vice President of the Silicon Systems Group Global Planning & Business Operations. Mr. Myers attended Kettering University where he obtained a B.S. in Electrical Engineering.

Robert Cresci

Mr. Robert J. Cresci is an Independent Director of Luminex Corp. He has been a Managing Director of Pecks Management Partners Ltd., an investment management firm, since September 1990. Mr. Cresci currently serves on the boards of directors of j2 Global Communications, Inc., a provider of outsourced, value-added messaging and communications services; OFS Capital Corporation, a business development company; Hancock Park Corporate Income, Inc. an affiliate company of OFS Capital Corporation; CIM Commercial Trust Corporation, a real estate investment trust; and Presbia PLC, a medical device company. Mr. Cresci holds an undergraduate degree in Engineering from the United States Military Academy at West Point and holds an M.B.A. in Finance from the Columbia University Graduate School of Business.

Stephen Eck

Dr. Stephen Eck is Independent Director of the Company. Dr. Eck has been the Vice President, Oncology Medical Sciences of Astellas Pharma Global Development, a global pharmaceutical company, since 2011. Prior to joining Astellas Pharma Global Development, Dr. Eck was the Vice President, Translation Medicine & Pharmacogenomics at Eli Lilly & Co., a global pharmaceutical company, from 2007-2011. Dr. Eck holds a B.S. in Chemistry from Kalamazoo College, a Ph.D. in Chemistry from Harvard University and an M.D. from the University of Mississippi.

Thomas Erickson

Mr. Thomas W. Erickson is an Independent Director of Luminex Corp. He served as chairman of the board of Western Dental Services, Inc., a dental practice management company until September 2015. Previously, he served as an interim Chief Executive Officer of Western Dental Services, Inc. and as a Senior Advisor to New Mountain Capital, LLC, a private equity firm, chairman of Inmar, Inc., a reverse logistics and revenue recovery company, chairman and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of PATHCare, Inc., an operator of long term care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim president and chief executive officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals, and interim president and chief executive officer and director of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Mr. Erickson currently serves on the board of directors of 3D Systems, American Renal Holdings, Inc., a national provider of kidney dialysis services, and Syncreon Group Holdings Limited, a contract logistics company. Mr. Erickson holds a Bachelor's degree from University of Iowa and an M.B.A. from Southern Methodist University.

Jim Kever

Mr. Jim D. Kever is an Independent Director of Luminex Corp., since December 1996. He is a founding member of Voyent Partners, L.L.C. (“Voyent”), a private investment company. Mr. Kever served as co-chief executive officer of the transaction services division of WebMD Corporation, a provider of healthcare transaction, information and technology services, from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles Transnational Corporation, a contract research company providing a wide range of clinical research services for biotech and pharmaceutical clients. From August 1995 through March 1999, Mr. Kever was the president and co-chief executive officer of Envoy Corporation (“Envoy”), a provider of electronic transaction processing services for the healthcare industry. Mr. Kever serves on the boards of directors of 3D Systems Corporation ("3D Systems"), a provider of 3-D printing, rapid prototyping and manufacturing solutions, and has served as a director of Tyson Foods, Inc. ("Tyson"), a food processing company, ACI Worldwide, Inc., a payment systems company, and Emdeon Corporation, a provider of revenue and payment cycle solutions. Mr. Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.

Kevin McNamara

Mr. Kevin M. McNamara is an Independent Director of Luminex Corp. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Since February 2015, Mr. McNamara has served as chief executive officer of Censeo Health LLC, a provider of prospective health risk assessments for health plans and healthcare delivery organizations. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara also served as non-executive chairman from April 2005 through January 2006 of MedAvant Healthcare Solutions (f/k/a ProxyMed, Inc.), a provider of automated healthcare business and cost containment solutions for financial, administrative and clinical transactions in the healthcare payments marketplace, and served as interim chief executive officer and as a director of ProxyMed, Inc. from December 2004 through June 2005. Mr. McNamara previously served as chief financial officer and a director of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and a M.B.A. from the University of Richmond.

Edward Ogunro

Dr. Edward A. Ogunro, Ph.D., is an Independent Director of Luminex Corp. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott Laboratories' (“Abbott”), a global, broad-based healthcare company, spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott's Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott's Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym and divisional vice president for Abbott's Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro serves on the board of directors of the Myeloproliferative Neoplasms Research Foundation (a not for profit organization). Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.

Matthew Scalo

Basic Compensation

Name Fiscal Year Total

G. Walter Loewenbaum

333,988

Nachum Shamir

3,630,790

Harriss Currie

1,117,020

Richard Rew

894,589

Todd Bennett

--

Nancy Fairchild

--

Tadd Lazarus

887,281

Randall Myers

856,083

Robert Cresci

180,990

Stephen Eck

146,977

Thomas Erickson

177,976

Jim Kever

164,490

Kevin McNamara

198,990

Edward Ogunro

182,990

Matthew Scalo

--
As Of  30 Dec 2016